Laure-Anne Teuwen, a medical oncologist at the University Hospital of Antwerp,...
Two investigations were presented concerning RAS-wildtype unresectable...
In the ADJORL1 study, the efficacy and safety of nivolumab were investigated as...
The latest findings from the Survival Update of the DESTINY-Breast04 trial were...
The LIBRETTO-531 study was specifically structured to explore the optimal...
The research of Dr Natasha Honoré, medical oncologist at UC Louvain, Brussels...
Prof Christine Gennigens, a medical oncologist at CHU de Liège, and Prof Els...
The ALINA trial was presented in the Presidential Session at ESMO 2023 by Prof...
The ESMO 2023 conference featured exciting data on lung cancer, including...
Prof Herbert Loong, representing the Chinese University of Hong Kong, presented...